SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 597.80 |
| Enterprise Value ($M) | 566.33 |
| Book Value ($M) | 133.38 |
| Book Value / Share | 1.88 |
| Price / Book | 4.48 |
| NCAV ($M) | 131.27 |
| NCAV / Share | 1.85 |
| Price / NCAV | 4.55 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.77 |
| Return on Assets (ROA) | -0.62 |
| Return on Equity (ROE) | -0.69 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 16.87 |
| Current Ratio | 16.87 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 145.76 |
| Assets | 147.86 |
| Liabilities | 14.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ameriprise Financial Inc | 5.45 | -7.35 | |
| 13G/A | State Street Corp | 4.80 | -12.67 | |
| 13G/A | Millennium Management Llc | 0.20 | -95.05 | |
| 13G/A | Nuveen Asset Management, LLC | 2.88 | ||
| 13G/A | Teachers Advisors, Llc | 2.88 | ||
| 13G/A | Tiaa Cref Investment Management Llc | 2.88 | -47.11 | |
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Tang Capital Partners Lp | 5.10 | 1.83 | |
| 13G/A | Vanguard Group Inc | 6.65 | 41.05 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -99.99 | |
| 13G | BlackRock, Inc. | 7.50 | 320.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 383,398 | 2,059,728 | 18.61 | |
| 703,474 | 4,224,689 | 16.65 | |
| 895,791 | 4,455,894 | 20.10 | |
| 593,123 | 2,471,324 | 24.00 | |
| 1,008,267 | 4,262,182 | 23.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACRV – Acrivon Therapeutics, Inc. | ADMA – ADMA Biologics, Inc. |
| AFMD – Affimed N.V. | ANIP – ANI Pharmaceuticals, Inc. |
| APGE – Apogee Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io